Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 19% ± 3% | |
| classical monocyte | 4 studies | 21% ± 3% | |
| conventional dendritic cell | 3 studies | 25% ± 5% | |
| non-classical monocyte | 3 studies | 24% ± 5% | |
| epithelial cell | 3 studies | 32% ± 4% | |
| endothelial cell | 3 studies | 21% ± 6% | |
| ciliated cell | 3 studies | 22% ± 3% | |
| macrophage | 3 studies | 23% ± 4% | |
| dendritic cell | 3 studies | 29% ± 7% | |
| natural killer cell | 3 studies | 19% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 18% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1079.85 | 1445 / 1445 | 100% | 18.17 | 183 / 183 |
| liver | 100% | 757.37 | 226 / 226 | 100% | 31.60 | 406 / 406 |
| ovary | 100% | 872.41 | 180 / 180 | 100% | 35.10 | 430 / 430 |
| skin | 100% | 1219.50 | 1809 / 1809 | 100% | 41.49 | 472 / 472 |
| thymus | 100% | 1212.78 | 653 / 653 | 100% | 36.48 | 605 / 605 |
| uterus | 100% | 1093.05 | 170 / 170 | 100% | 36.33 | 459 / 459 |
| brain | 100% | 930.90 | 2639 / 2642 | 100% | 36.20 | 705 / 705 |
| lung | 100% | 1086.48 | 577 / 578 | 100% | 33.35 | 1155 / 1155 |
| breast | 100% | 1141.34 | 459 / 459 | 100% | 42.10 | 1116 / 1118 |
| kidney | 100% | 1065.30 | 89 / 89 | 100% | 26.85 | 898 / 901 |
| stomach | 100% | 848.04 | 359 / 359 | 100% | 27.41 | 285 / 286 |
| adrenal gland | 100% | 1388.76 | 258 / 258 | 100% | 28.28 | 229 / 230 |
| prostate | 100% | 1169.48 | 245 / 245 | 99% | 34.35 | 499 / 502 |
| intestine | 100% | 1022.63 | 966 / 966 | 99% | 31.69 | 523 / 527 |
| pancreas | 100% | 598.41 | 327 / 328 | 99% | 31.62 | 177 / 178 |
| bladder | 100% | 1083.43 | 21 / 21 | 99% | 36.54 | 499 / 504 |
| adipose | 100% | 1135.52 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1068.74 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 55.42 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 49.95 | 29 / 29 |
| spleen | 100% | 1451.32 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 31.08 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 65.25 | 1 / 1 |
| heart | 100% | 737.42 | 859 / 861 | 0% | 0 | 0 / 0 |
| muscle | 100% | 698.41 | 801 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 96% | 882.26 | 894 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| Gene name | COMMD5 |
| Protein name | COMM domain-containing protein 5 (Hypertension-related calcium-regulated gene protein) (HCaRG) COMM domain-containing protein 5 COMM domain containing 5 |
| Synonyms | HT002 |
| Description | FUNCTION: May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes . Negatively regulates cell proliferation. Negatively regulates cell cycle G2/M phase transition probably by transactivating p21/CDKN1A through the p53/TP53-independent signaling pathway. Involved in kidney proximal tubule morphogenesis (By similarity). Down-regulates activation of NF-kappa-B . . |
| Accessions | Q9GZQ3 ENST00000402718.4 E9PJE4 ENST00000543949.2 ENST00000305103.4 ENST00000533270.1 ENST00000529143.1 H0YEQ6 ENST00000530332.1 ENST00000450361.2 |
